Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

R
Raabe A. - The administration of recombinant coagulation factor VIIa (rFVIIa) during neurosurgical procedures
  - Increased thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae
  - The risk of postoperative hemorrhage after intracranial surgery following early Nadroparin administration – results of a prospective study
Rábano J. - Hypercoagulability in cerebrovascular disease (CD): factor V Leiden, prothrombin G20210A and MTHFR C677T mutations and polymorphism in the annexin V kozac sequence
  - TNF-alpha promoter polymorphisms (-238 and -308) in patients with cerebrovascular disease
Rabbat C. - Baseline thrombophilic markers do not predict deep venous thrombosis in medical–surgical ICU patients
  - Levels of D-dimer do not predict deep venous thrombosis in medical–surgical ICU patients
Rabe E. - Treatment of thrombotic complications and prophylactic use of protein C concentrate in two homozygous protein C deficient patients during surgery
Rabie T. - Targeting of the collagen binding site on glycoprotein VI is not essential for in vivo depletion of the receptor
Rabinovich O. - High levels of factors VIII, IX and XI in patients with a thromboembolic event
  - Safety considerations of Enoxaparin as an alternative to oral anti-coagulants in high risk cardioembolic patients with a programed surgical procedure. SWITCH trial
Rabot S. - Prevention of wine consumption on thrombosis but not on atherosclerosis in ApoE-/- mice
Rached R. A. - Partial results of the incidence of Thrombocytopenia Induced Heparin
Rached R. A. - Analysis of the effectiveness of the D-Dimer test to exclude acute venous thromboembolism
Rached R. D. V. A. - Analysis of the effectiveness of the D-Dimer test to exclude acute venous thromboembolism
Rached R. A. - Comparison of the point-of-care method for oral anti-coagulation control with the conventional method
Rached R. D. V. A. - Comparison of the point-of-care method for oral anti-coagulation control with the conventional method
Racine E. - Improving bridge-out therapy with low-molecular-weight heparin in an urban, inner city medical center
Racz H. - A type 2A (Group II) von Willebrand disease mutation (Leu1503Glu) associated with a minimal loss of high molecular weight von Willebrand factor (VWF) multimers
Radder J. K. - Subpopulations of tissue factor-exposing microparticles from platelets and T-cells colocalize leukocytic antigens in uncomplicated human type 2 diabetes
Radojkovic D. - The FV Leiden, FII G20210A and MTHFR C677T mutations in healthy and thrombophilic Yugoslav population
Radossi P. - Intron 1 factor VIII gene inversion in patients with severe hemophilia A
  - Molecular genotyping of the Italian cohort of patients with hemophilia B
  - Contemporary total hip and knee replacement in A patients with haemophilia and high titre of inhibitors to FVIII by using recombinant FVIIa (novoseven) continuous infusion
Radulescu L. - Effects of enoxaparin on high glucose induced activation of human endothelial cells
Radwan J. - Comparison of fibrinogen and S2238 as substrates for the study of multiple, active thrombin forms in the process of plasma clotting
Radziwon P. - Calpain inhibitor calpeptin enhances the activity of the 20S proteasome in intact and calcium ionophore-stimulated platelets
Rafail S. - Thrombophilia and pregnancy
Rafowicz A. - Response to DDAVP in mild/moderate hemophilia A patients according to the underlying factor VIII genotype
Ragazzo M. - Increased platelet superoxide anion production in patients with hypertension: role of AT1 receptors
Ragni G. - Embryo implantation after assisted reproductive procedures and maternal thrombophilia
Rahiminejad M. S. - Coagulation disorders in b-thalassemic patients in Southern Iran
Rahman S. - The influence of the substitution of arginine within the RGD tripeptide motif of dendroaspin on its activity as a potent inhibitor of platelet aggregation and cell adhesion
Raife T. J. - Lepirudin (Refludan®) prevents shigatoxin-induced hemorrhagic colitis/hemolytic uremic syndrome
Räike P. - Platelets regulate protein C activity
Raineri S. M. - Coagulation and complement inhibitors levels predict outcome in patients with severe sepsis
Rainger G. E. - Endothelial cells cocultured with monocytes are activated to support the adhesion of flowing leukocytes by a combination of TNF-a IFN-g and TGF-b1, a process that is progressively ablated as monocytes differentiate into macrophages
Rainger G. E. - Conditioning of endothelial cells by different levels of fluid shear stress modulates their ability to induce each stage of neutrophil adhesion and migration in response to TNF-a but not IL1-b
  - Neutrophils recruited by TNF-a stimulated endothelial cells down regulate subsequent endothelial VCAM-1 expression and inhibit the adhesion of a secondary bolus of flowing peripheral blood lymphocytes
Rainger G. E. - Neutrophils rapidly recruited by TNF-a stimulated endothelial cells can exit the sub endothelial environment by reverse transmigration over hours: is this a novel route for neutrophil clearance from inflamed tissue?
Raisky O. - Identification and characterisation of MIP-1b and VE-Cadherin as important markers of acute rejection after human heart transplantation
Raith M. - A microsatellite polymorphism in the Heme Oxygenase – 1 gene promoter is associated with increased serum bilirubin and HDl levels but not with a decreased risk for coronary artery disease
Raith C. - Pilot introduction study of a needleless transfer device (BAXJECT) for reconstitution of Factor VIII concentrates for infusion
Raith M. - Platelet glycoprotein mRNAs are expressed in megakaryocytes and platelet like cells and are regulated during differentiation
Rajab A. - Impaired prothrombinase activity of Factor X Gly381Asp results in severe familial CRM + FX deficiency
Rajani R. - Elevated factor VIII: a possible link between periodontal disease and acute coronary syndrome
Rak J. - Paradoxical effect of unfractionated heparin in combination with streptokinase on arterial recanalization
Rakicevic LJ. - The FV Leiden, FII G20210A and MTHFR C677T mutations in healthy and thrombophilic Yugoslav population
Rakoto F. - The thrombin generation test (TGT) may be a predictive parameter for thrombus formation during endovascular embolization of cerebral aneurysms
Rakov D. V. - Loss of stability of the baseline state and the coagulation triggering: a mathematical modeling study
  - Thrombin generation in clotting factor deficiency: mathematical model
Rakow A. - Benefit and risk of heparin addition in maintaining peripheral venous catheters in neonates – a prospective, double-blind, placebo-controlled trial
Ramacciotti E. - Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis
Ramacciotti E. - Efficacy and safety of once-daily Enoxaparin given in the outpatient setting compared with in-hospital unfractionated heparin for treatment of proximal lower limb deep-vein thrombosis
  - Cost analysis of the treatment of patients with post–thrombotic syndrome in Brazil
Ramage J. - Hypercoagulability in inflammatory bowel disease
Ramanathan R. - Agreement between FXIII activity assays and calibrator plasma pools: the need for a FXIII reference standard with regulatory recognition
Ramasamy I. - Kinetics of tissue type plasminogen activator (t-PA) and its derivatives
Ramdani B. - The mannometric profile of native arteriovenous fistulas in the Avicenne Hemodialysis Center of Casablanca (preliminary results)
Ramén L. - Quantitative real-time reverse transcription-PCR (RT-PCR) assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1 and tissue metalloproteinase inhibitor type 1 gene expression and protein levels in endometriosis
Ramon R. - The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study
  - Anti-prothrombin antibodies in patients with recurrent venous thromboembolism
Ramos C. D. - Evaluation of skeletal muscle perfusion in a hindlimb ischemia model using 99 mTc-sestamibi scintigraphy
Ramsis N. - Thrombin activatable fibrinolysis inhibitor in thrombophilic patients with activated protein C resistance
Ramström S. - The relative importance of P2Y12/P2Y1 in thrombin/ADP-induced platelet activation and true synergistic action in-between inhibition of P2Y12 and P2Y1
  - Platelet-dependent coagulation amplification – role of tissue factor, factor XI and factor XII
  - The choice of tubes for blood collection – a plastic tube is not enough
  - Effects of anticoagulation, red blood cells and number of platelets on coagulation and clot elasticity measured by free oscillation rheometry
Ramuscello S. - Venice DVT
Ran S. - The use of phospholipid-dependent clotting assays to characterize the cell-surface procoagulant activities of T-lymphoblastoid cell lines
  - Basal levels of phosphatidylserine exposure on the cell-surface of T-lymphoblastoid and monocytoid cells: relationship to Prothrombin and FX activation, and Tissue Factor activity
Rånby M. - Studies of blood coagulation and platelet function in thoracic surgery utilizing a point of care instrument, a free oscillation rheometer
Rance J. - Roles of low specificity and cofactor interaction sites on thrombin during factor XIII activation: competition for cofactor sites on thrombin determines its fate
Rance J. B. - Human endothelial cell protein C receptor (EPCR) expression: role of proximal and distal 5'-gene regulatory elements
RAnd M.L. - Procoagulant surface expression on activated human platelets persists despite increased aminophospholipid translocase activity
Rand M. - Triple heterozygosity in the alphaIIb gene of a patient with Glanzmann thrombasthenia and platelets with a low alphaIIbbeta3 content
Rand M. - Stability of dilutions of the recombinant factor VIII Kogenate FS stored in syringes
Rand J. - Annexin A5 resistance in the antiphospholipid (aPL) syndrome
Rand M. - Senescent rabbit platelets, or rabbit platelets with experimentally shortened survival, are apoptotic with increased surface exposure of procoagulant phosphatidylserine (PS)
Rand M. L. - Underlying platelet function disorders and von Willebrand disease in children with epistaxis or menorrhagia
Randell E. - Combined carrier status of prothrombin 20210 A and factor XIII-A L34 alleles as a strong risk factor for myocardial infarction: evidence of a gene–gene interaction
Ranganathan S. - Diverse roles of LRP in clearance of proteases and in signaling
Rangel-Filho A. - Genetic and physical mapping of the platelet disorder in the fawn-hooded hypertensive rat
Rani M. R. S. - Lysophosphatidylcholine induction of chemokines in human microvascular endothelial cells is dependent on the activation of MAP kinases and PI3 kinase
Ranieri P. - Identification of a dysfibrinogenemia characterized by marked resistance to fibrinolysis in an asymptomatic woman
Rankin A. - The low frequency allele of glycoprotein VI raises the threshold for platelet activation by collagen and collagen-related peptides
  - Platelet glycoprotein VI has evolutionary conserved immunoglobulin domains, but a highly polymorphic stem and cytoplasmic domain
Ransohoff R. M. - Lysophosphatidylcholine induction of chemokines in human microvascular endothelial cells is dependent on the activation of MAP kinases and PI3 kinase
Rao A. K. - Association of impaired agonist stimulated platelet GPIIb–IIIa activation and pleckstrin phosphorylation with transcription factor CBFA2 mutation: proteins regulated by CBFA2 play a role in GPIIb-IIIa activation
Rao C. - Standardization of circulating endothelial cell enumeration in whole blood
Rao V. S. - cDNA sequence of the nonenzymatic subunit of pseutarin C, a prothrombin activator from the eastern brown snake (Pseudonaja textilis): its structural similarity to blood coagulation factor V
Rao A. K. - Anti-platelet agents clopidogrel and aspirin inhibit expression of tissue factor procoagulant activity in patients with peripheral artery disease
Rao V. S. - The catalytic subunit of pseutarin C, a group C prothrombin activator from Pseudonaja textilis is structurally similar to blood coagulation factor X
  - Comparative molecular modeling of the nonenzymatic subunit of pseutarin C, a prothrombin activator from the venom of eastern brown snake
Rao A. K. - Characterization of 5'-upstream region of human phospholipase C-beta2 gene in megakaryocytic cell line
Rao L. V. M. - Anti-apoptotic effect of coagulation factor VIIa
Rapson D. - A type 2A (Group II) von Willebrand disease mutation (Leu1503Glu) associated with a minimal loss of high molecular weight von Willebrand factor (VWF) multimers
Rapson D. - Issues arising in application of the ISTH disseminated intravascular coagulation (DIC) scoring system: the need for modification before prospective validation
Rapson D. A. - The type 1/type 2M von Willebrand disease dilemma: findings from the Canadian Type 1 VWD study
Rascher W. - Disseminated intravascular coagulation after varicella infection
Rasko J. E. J. - A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Raskob G. E. - Oral SNAC-heparin vs. enoxaparin for preventing venous thromboembolism following total hip replacement
Raskob G. - Evaluating bleeding complications of thromboprophylaxis after hip replacement: a systematic review
Rasmussen J. T. - Limited exposure of phosphatidylserine on stimulated platelets is necessary for procoagulant activity and provides binding sites for lactadherin
Rasmussen M. S. - Prolonged thromboprophylaxis with low molecular weight heparin (dalteparin) after major abdominal surgery: the FAME study
Rasmussen J. T. - Anticoagulant function of lactadherin correlates with phosphatidyl-L-serine specificity
Rasmussen E. - Spiral computed tomography has a higher sensitivity and specificity than d-dimer in the diagnosis of acute pulmonary embolism
Rasmussen M. S. - Prolonged thromboprophylaxis with low molecular weight heparin (tinzaparin) following major general surgery primarily for cancer: An individual patient data meta-analysis
Rasmussen E. - A comparison of spiral computed tomography and latex agglutination D-dimer assay in acute pulmonary embolism using pulmonary arteriography as Gold Standard
Rastegar Lari G. - Inhibitor against factor VIII in developing countries; the first case of immune tolerance induction in Iran
Rastegar Lari G. - Identification of intron 1 and 22 inversion mutation in the factor VIII gene of 94 Iranian families with hemophilia A
Rasuli P. - The bedside investigation of pulmonary embolism diagnosis (BIOPED) study- a triple blind randomized control trial comparing initial bedside diagnostic tests to standard care (initial V/Q scan) in the investigation of patients with suspected PE
Raszeja-Specht A. - Changes in von Willebrand factor concentration and blood loss during cardiac surgery
  - Thrombophilic risk factors of ischemic stroke in children
Rath J. - cGMP regulates thrombopoietin-induced CD34+ human stem cell proliferation and differentiation into megakaryocytes
Rätsep I. - Comparison of platelet aggregation in venous and arterial blood
Rattazzi M. - Risk factors for venous thromboembolism in chronically bedridden patients admitted to the Hospice Unit
Rauch R. - Laborious way to an efficient prophylaxis: Homozygous prothrombin G20210A mutation in a neonate with cardiac diverticulum
Rauch R. - Non-catheter related pulmonary artery thrombosis in a premature
Rauh M. - Thrombin generation in patients with stroke and elevated factor VIII levels
Rauova L. - PF4 and heparin form high molecular weight complexes that is central to the pathogenesis of Heparin-Induced Thrombocytopenia
Rausch D.J. - Sickle blood contains tissue factor positive microparticles derived from endothelial cells and monocytes
Raut S. - Studies of anti-idiotypic polyclonal antibodies developed against antihuman Factor VIII monoclonal antibodies
  - Inhibitory effects of human anti-factor VIII monoclonal antibodies and their neutralization by respective anti-idiotypic antibodies using Thrombin Generation Test
  - Variability in factor VIII concentrate measurement: results from SSC Field Collaborative Studies
Raut S. - Promotion of thrombin generation at low FVIII concentrations by FIXa
Ravanbod R. - Effect of ergometric exercise on factor VIII coagulant activity in patients with mild and moderate hemophilia A
Rawal A. - Correlation of supra-therapeutic (ST) International Normalized Ratio (INR) with vitamin-K-dependent factors (VKDF)
Rawle F. E. M. - The use of three hemophilia A mouse models to illustrate strain-specific differences in immune responses to FVIII protein replacement via protein infusion or adenoviral gene therapy
Ray M. - Point-of-care testing shows clinically relevant variation in the degree of inhibition of platelets by standard dose abciximab therapy during percutaneous coronary intervention
Raymer R. A. - Comparative response of plasma VWF in normal and von Willebrand disease dogs to up-regulation of VWF mRNA by Interleukin-11 vs. Weibel–Palade body release by Desmopressin (DDAVP)
Raymond F. - The bedside investigation of pulmonary embolism diagnosis (BIOPED) study- a triple blind randomized control trial comparing initial bedside diagnostic tests to standard care (initial V/Q scan) in the investigation of patients with suspected PE
Razavi M. - A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Razso K. - Anti-phospholipid syndrome during pregnancy: only the high-dose of LMWH thromboprophylaxis is successful
Rázsó K. - The role of platelet concentrate in the treatment of von Willebrand's disease
Razzaboni E. - Emotional impact of testing for inherited thrombophilia
Razzari C. - Genetically defined protein S (PS) deficiency is associated with venous thrombosis
  - High-level in vitro expression of protein S after modifications of protein S cDNA
Razzari C. - PROSIT: functional analysis of identified PROS1gene mutations
Rdzanek A. - Activity of endogenous fibrinolytic system induced by exercise ECG test in patients with previous positive ECG-exercise test but without essential atherosclerotic changes in coronaries during angiography
Real M. M. D. V. - Prothrombin mutation G20210A, and not factor V Leiden, is a significant risk factor for cerebral venous thrombosis in 27 Brazilian patients
Rebarber A. - Patients with adverse pregnancy outcome have lower levels of protein Z and protein S compared to patients with normal pregnancy outcome
  - Normal pregnancy is associated with decreased protein Z levels in the second and third trimesters compared to early pregnancy
Reber G. - European forum on antiphospholipid antibodies standardization group: results of the 2nd round on antibeta2glycoprotein I home-made assays
Reber G. - Aspirin inhibits VCAM-1 expression induced by antiphospholipid antibodies
  - Effects of statins on adhesion molecules expression in endothelial cells
Reboul M. P. - LPS-activation of THP-1 cells: effect of anti-thrombin studied by in vivo footprinting of the tissue factor (TF) gene promoter
Redaelli R. - VWF:RCo assay implementation on automated coagulometer
Reddy B. - Safety and tolerability of argatroban anticoagulation in patients with end-stage renal disease undergoing hemodialysis: a prospective study
Reding M. T. - Successful liver transplantation in a hemophilia A patient with high titer factor VIII inhibitor
Reekers J. A. - Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremities: survival, risk factors and post–thrombotis syndrome
Regan L. - Screening for thrombophilia: an economic assessment
  - Thrombophilia in pregnancy, combined oral contraceptives and hormone replacement therapy users: a systematic review
  - The risk of thromboembolism and the effectiveness of prophylactic treatment in thrombophilia patients undergoing major orthopaedic surgery: a systematic review
Reganon E. - Inflammation and thrombogenic activity in terminal heart failure patients and heart transplantation: a prospective study
  - Endothelial and angiogenesis activity in terminal heart failure and heart-transplant patients: a prospective study
Reges R. V. - Factor XIII (FXIII) Val34Leu, His95Arg and G30899A polymorphisms and the risk of deep venous thrombosis
Regina S. - Changes in the platelet count (PC) after cardiopulmonary bypass (CPB) can efficiently predict the development of pathogenic heparin- dependent antibodies (Abs)
Regina S. - Frequency of platelet glycoproteins alpha2807T and GPIbalpha Kozak polymorphisms in central retinal vein occlusion
Regnault V. - Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors in the Stanislas Cohort
  - Thrombinography can differentiate bleeding from nonbleeding patients with prolonged APTT
Regnault V. - The thrombin potential in contrast to clotting times is only slightly modified after uncomplicated heart valve replacement in adults
  - Increased thrombin potential due to acquired activated protein C resistance in patients with lupus anticoagulants
Rehak T. - Increased von-Willebrand-facor-binding to platelets in neonatal plasma
Rehault S. - Plasminogen activator inhibitor-1 (PAI-1) confers a survival advantage to breast cancer cells
Reibetanz J. - Factor XI: its role in thrombotic disease of patients with factor V Leiden
Reichl H. E. - Removal of a BSE-derived agent by ion exchange chromatography used in the manufacture of a high purity factor VIII concentrate
Reid U. - Unfractionated heparin, but not a low-molecular-weight heparin (Clivarin), mediates differential generation of anti-heparin-PF4 antibodies in orthopedic surgery patients: Pathophysiologic and pharmacologic implications
  - Differential effects of unfractionated heparin and a low molecular weight heparin on anti-thrombin activity during the treatment of deep vein thrombosis
Reijerkerk A. - Tissue-type plasminogen activator is a multiligand cross-b structure receptor
Reilly M. P. - PF4 and heparin form high molecular weight complexes that is central to the pathogenesis of Heparin-Induced Thrombocytopenia
Reilly D. - An analysis of the platelet transcriptome using commercial microarrays
  - Identification of an integrin-associated chloride channel in human platelets
Reineri S. - Activation of p38 MAP kinase in human platelets stimulated by von Willebrand factor
Reiners S. - Platelet function under aspirin, clopidogrel and both after ischemic stroke. A case-crossover study
Reininger A. J. - Identification of a quantal unit mediating platelet tethering and microparticle formation through glycoprotein Ibalpha–VWF interaction
Reininger A. J. - Rapid and automated quantification of the kinetics of thrombin formation using the Thrombin Dynamics Test (TDT)
Reipert B. M. - Differentiation of factor VIII-specific memory B cells into anti-factor VIII antibody-secreting cells requires direct interaction between memory B cells and activated T cells but is not dependent on factor VIII-specific T cells
Reis C. V. - Recombinant Lopap (a prothrombin activator from Lonomia obliqua) has a very conservative structure of lipocalins
Reis E. D. - b3-integrin deficiency and antibody-mediated b3-integrin inhibition have paradoxical effects on murine smooth muscle cell proliferation and the development of intimal hyperplasia after vascular injury
Reisinger M. - Impact of platelet glycoprotein Ibalpha Kozak polymorphism on risk of ischemic cerebrovascular events
Reitenauer M. - Comparison of two methods to assess platelet activation during and after CABG
Reiter R. - Changes in ADAMTS13 (vWF cleaving protease) activity after induced acute release of von Willebrand factor
Reitsama P. H. - Rapid arterial thrombus formation after endothelial injury in streptozotocin-induced diabetic mice
  - Effect of pravastatin on plasma markers of coagulation and inflammation in type 2 diabetes
Reitsma P. H. - Plasma levels of the pro-inflammatory mediators TNF-alpha, IL-6 and IL-8 are risk factors for venous thrombotic disease
Reitsma P. H. - Effect of hyperhomocysteinemia on coagulation activation and endothelial cell activation
  - CYP2C9 polymorphisms have differential effects on the quality of acenocoumarol treatment
  - Coagulant phenotype determines the outcome of septic peritonitis
Reitsma P. H. - Coagulation factor profiles respond strongly during human endotoxemia
Reitsma P. H. - Tissue factor itself is vital for the development of cell types with constitutive tissue factor expression but not for cell types without such expression
  - A functional single-nucleotide polymorphism in the thrombin-activatable fibrinolysis inhibitor (TAFI) associated with risk and outcome of meningococcal disease (MD)
  - CYP2C9 polymorphisms have differential effects on acenocoumarol metabolism, but do not increase bleeding risk
  - A mouse model for inhibitor development in mild hemophilia A
  - Tissue factor (TF) and high-sensitivity CRP (HS-CRP) in patients with peripheral arterial disease (PAD) undergoing peripheral bypass surgery or angioplasty: a retrospective study
  - Blood-borne tissue factor aggravates the outcome of endotoxemia
  - Differential effects of tissue factor haploinsufficiency during LPS stimulation
Relou I. A. M. - PECAM-1 inhibits LDL-signaling in platelets
Relou I. - Platelet sensitization is mediated by Apolipoprotein E Receptor 2
Remijn J. A. - Potential reversal agents for the long-acting pentasaccharide idraparinux
Remkes M. G. H. - CYP2C9 polymorphisms have differential effects on the quality of acenocoumarol treatment
  - CYP2C9 polymorphisms have differential effects on acenocoumarol metabolism, but do not increase bleeding risk
Remkova A. - Serum homocysteine in chronic liver diseases – risk factor for thrombosis or protection against thrombosis?
Remones V. - Tissue Factor-603 A–G promoter polymorphism is associated with human monocyte constitutive but not with LPS induced gene expression
Renckens R. - Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia
Rendu F. - Intravenous immunoglobulins G modulate calcium signals, von Willebrand factor secretion and nitric oxide metabolism in human endothelial cells
  - Thrombomodulin regulates activity, localization and expression of nitric oxide synthase inhuman umbilical vein endothelial cells (HUVECs)
Reneman R. S. - In vivo involvement of ADP in thromboembolism through its receptors P2Y1 and P2Y12
Renné T. - Proteoglycans dock kininogens to cells and regulate generate bradykinin generation
Renner W. - Association of a common 936 C/T polymorphism in the gene of vascular endothelial growth factor and VEGF plasma levels
Rentz A. - Health-related quality of life in adults with hemophilia: the patient perspective
Reny J. - ADP-induced platelet aggregation is associated with P2Y12 gene sequence variations in healthy subjects
Reny J. L. - Tissue Factor-603 A–G promoter polymorphism is associated with human monocyte constitutive but not with LPS induced gene expression
  - Factor II 20210 G-A but not Factor V Arg506Gln gene polymorphism is associated with peripheral arterial disease in a case-control study
Repine T. - Menorrhagia due to a qualitative deficiency of plasminogen activator inhibitor-1: case report
Reséndiz J. C. - Tyrosine kinases regulate the activation of phosphatidylinositol 3-kinase in platelets stimulated by the PAR1-activating peptide
Retzios A. - Continuing clinical evaluation of an advanced category recombinant FVIII, antihemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in previously treated patients (PTPs)
Retzlaff S. - Overexpression of basic fibroblast growth factor (bFGF) in the bone marrow of patients with acute myeloid leukemia: a potential role for bFGF as an autocrine growth factor
Retzlaff K. L. - The sorting signal for von Willebrand factor (vWF) granular storage lies within the first 140 amino acids of the D2 domain of the VWF propeptide (VWFpp)
Reus S. - Prospective study of the risk factors for the development of post–thrombotic syndrome after proximal deep vein thrombosis
Reutelingsperger C. P. M. - Screening for annexin A5 gene mutations and the risk of the C-1T mutation in venous thrombosis and myocardial infarction
  - The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma
Revel-Vilk S. - Use of low molecular weight heparin in children with thromboembolic events; predictors for bleeding and recurrence on therapy
Reverdiau P. - Transcriptional silencing of TFPI-2 gene by hypermethylation of the promoter in choriocarcinoma cells
  - Demonstration of a tissue factor pathway inhibitor-2 (TFPI-2) mRNA synthesis by pure villous cytotrophoblast cells isolated from term human placentas
  - Quantitative evaluation of TFPI-2 and MMP-9 expression in nonsmall cell lung cancer
Reverter J. C. - Polymorphisms of platelet glycoproteins Ib-a and Ia/IIa: relationship with early arteriosclerosis and arterial thrombosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus
Reverter J. C. - Effect of antiphospholipid antibodies in the activation of the contact complex: importance in the obstetric complications of the antipospholipid syndrome
Rey E. - Specific and nonspecific antiphospholipid antibodies in recurrent fetal loss: a meta-analysis
Reyes E. - Functional anti-heparin-PF4 antibody-mediated platelet–endothelial cell interactions: modulation of tissue factor activity involved in the HIT pathogenesis
Reyes J. L. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Reyes E. - Bovine heparin results in higher generation of functional anti-heparin-PF4 antibodies than porcine heparin following coronary artery bypass surgery
Reyes J. L. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Reynaud J. - A retrospective evaluation of the use of B-domain deleted recombinant Factor VIII (ReFacto®) administered by continuous infusion during surgical procedures
  - Treatment of patients with inhibitors with FEIBA: the French experience from 1995 to 1999
Reynolds T.C. - A randomized, double-blind, placebo-controlled study of the safety and pharmacokinetics of a single dose of recombinant Factor XIII in healthy volunteers
Rezaee F. - Tissue-type plasminogen activator (t-PA) gene deletion in apoE3-Leiden mice delays progression of cholesterol-induced atherosclerotic lesion
  - A proteomic approach to identify plasma lipoprotein-associated proteins with a potential role in atherothrombosis
Rezaie A. R. - Role of basic residues of proexosite 1 on prothrombin in the prothrombinase complex
  - The fourth epidermal growth factor-like domain of thrombomodulin interacts with the basic exosite of protein C
Rezaie R. - Kinetics of Inhibition of Factor Xa and the Prothrombinase Complex
Rezende S. M. - High-level in vitro expression of protein S after modifications of protein S cDNA
Rhee S. G. - GPVI- and GPIb/V/IX-induce tyrosine phosphorylation at Syk and PLCg2 at distinct sites
Rhee J. S. - Regulation of neovascularization by a-defensins: a link between inflammation and angiogenesis
Rhodes S. - Evaluation of a clinical algorithm in nurse led DVT management to identify underlying malignancy
Rhodes S. - Management of pulmonary embolism: Can we consider outpatient treatment?
Ria L. - Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
  - Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
Ribba A.-S. - Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
Ribba A. S. - An in vivo model to study von Willebrand factor (VWF) clearance: fundamental aspects and application to the Arg1205His Vicenza mutation
  - Identification of seven new candidate mutations of ADAMTS13 gene in four French families related to congenital thrombotic thrombocytopenic purpura
  - Stability of 19 mutated recombinant von Willebrand factor to von Willebrand factor-cleaving protease (ADAMTS13)
  - In vitro expression of 4 novel mutations identified in type 1 von Willebrand disease patients
  - Mutation of cysteines 1157 or 1234 located within the D3 domain of Von Willebrand Factor causes intracellular retention of high molecular weight multimers
Ribeiro S. - Molecular basis of inherited anti-thrombin deficiency in Portuguese families: identification of underlying molecular defects and screening for additional thrombotic risk factors
Ricard C. - Successful use of rFVII for an hemorrhagic Port-a-cath insertion in a Fanconi's disease
Ricart J. M. - Circulating activated protein C in Behcet's disease and risk of thrombosis
Ricci M. - Asymptomatic venous thrombosis is a frequent event in protein C deficiency: a systematic ultrasound assessment of 208 family members with the 3363-C insertion mutation (IPCI: International Protein C Investigation)
Ricci Bitti P. E. - Emotional impact of testing for inherited thrombophilia
Rich J. S. - Bridging therapy for mechanical heart valves: a model comparing unfractionated and low molecular weight heparin
Richard B. - Thrombin regulates the expression of its cellular inhibitor protease nexin-1 in smooth muscle cells
Richard F. - Tissue factor pathway in carotid atherosclerotic plaques: relationships with clinical patterns and risk factors
Richards S. J. - Platelet CD109: evidence for a transmembrane homologue on monocytes?
Richardson M. - Fibrinolysis within the procoagulant VX-2 tumor of rabbit lungs in vivo: Anti-angiogenic behavior of fibrin(ogen) degradation products
Richel D. J. - Subsequent diagnosis of malignancy in patients presenting with an idiopathic venous thromboembolism – a number needed to screen and decision analysis based on the results of a prospective study
Richter G. - Proteases derived from Ficus carica activate human factor X
Richter H. - Prophylactic treatment of afibrinogenemia with the fibrinogen concentrate Haemocomplettan®
Rick M. E. - Acquired von Willebrand's disease not responding to Rituximab
Rickard K. - Screening for the Factor V Leiden mutation with a Russell's viper venom-based clotting test
Rickles F. R. - Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) may improve survival in patients with nonmetastatic malignancy and venous thromboembolism (VTE)
  - Long-term treatment with dalteparin low-molecular-weight heparin (LMWH) is more effective than oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE)
Riddell A. - Identification of a family with discrepant von Willebrand factor collagen binding assays (VWF:CB)
Riddell A. F. - Increased VWF antigen clearance in partial quantitative von Willebrand factor deficiency and reporting of a familial tendency
Riddell A. - Use of TEG® as a global measure of thrombogenicity in thrombophilia screening
Riddell A. F. - Combined modality inhibitor eradication in a patient with mild hemophilia A and comparison of methods of inhibitor monitoring
Ridderstråle W. - Anti-hypertensive treatment restores impaired local fibrinolysis in essential hypertension
Riding K. H. - Pre-surgical reversal of warfarin using recombinant activated factor VII (rFVIIa) in a pediatric patient with prosthetic heart valves
Ridker P. - Long-term, low-intensity warfarin for the prevention of recurrent venous thromboembolism: the PREVENT trial
Rieger S. - Platelet glycoprotein mRNAs are expressed in megakaryocytes and platelet like cells and are regulated during differentiation
Rienstra M. E. - Evaluation of a bed-side device to assess the APTT for heparin monitoring in infants
Ries M. D. - Acute myocardial infarction in a child with patent foramen ovale and atrial septal aneurysm
Riesen W. - Triglycerides show an immediate increase during anticoagulant therapy for DVT without increase in thrombin generation
Riess H. - Combined analysis of 2 studies on the clinical outcome over 6 months in patients with symptomatic acute deep vein thrombosis initially treated with one low-molecular-weight heparin
Riewald M. - Specificity of coagulation factor signaling
Riexinger T. - A cytochrome P450 2C8/9-derived EDHF inhibits platelet adhesion to endothelial cells in vitro
Riffo-Vasquez Y. - Platelet depletion abolishes eosinophil recruitment to the lungs and tissue remodelling in an allergic asthma model in mice
Rigal D. - In vitro flow cytometry and functional testing of fresh and cryopreserved platelets
Rigas J. - Secondary prevention of venous thromboembolic events (VTE) in patients with active malignancy: a randomized study of enoxaparin sodium alone vs. initial enoxaparin sodium followed by warfarin for a 180-day period
Rigby A. C. - Calcium ion-independent structure of the factor IX w-loop peptide, FIX(G4–Q11) and its interaction with phosphatidylserine
  - FIX Gla Domain: Identification and characterization of residues involved in the phosphatidylethanolamine/phosphatidylserine phospholipid membrane interaction
Riggos D. - Factor VIII inhibitor in a patient with multiple sclerosis and interferon regimen
Righini M. - Clinical usefulness of D-dimer according to clinical probability in patients with suspected pulmonary embolism
Rigotti P. - Plasma fibrinolytic capacity and 4G/5G polymorphism of PAI-1 gene in heart and kidney transplant recipients with or without steroid immunosuppression
  - Levels of anti-thrombin III activity in the plasma of cynomolgus monkeys after administration of recombinant human anti-thrombin III
Rigsby P. - Influence of flow on inhibition of platelet dependent thrombin generation by an anti-GPIIb/IIIa antibody
  - A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique
Riikonen P. - Development of hemostasis in the very low birth weight premature infants
  - Hand computer and Internet for collection and presentation of patient diary data in a Nordic clinical multicenter safety surveillance study of ReFacto®
Riina M. F. - Chemotherapy-induced activation of hemostasis: the role of d-dimer
Riina F. - Coagulation and complement inhibitors levels predict outcome in patients with severe sepsis
Rijken D. C. - Clot penetration and fibrin binding of amediplase
Rijken D.C. - A comparison of assay methods for thrombin activatable fibrinolysis inhibitor (TAFI)
Riker R. R. - APTT transmittance waveform analysis in a cohort of septic patients
Rinaldi G. - Clinical quality assessment program for the oral anti-coagulant clinic: preliminary report of a multicentric Italian exercise
Riondino S. - Enhanced TNF-a and oxidative stress in patients with heart failure: effect of TNF-a on platelet O2 production
Riondino S. - cAMP inhibits convulxin-induced calcium mobilization; differences with collagen
Riondino S. - Aggregometric evidence of a progressive reduction of platelet sensitivity to aspirin
Riou J. P. - Comparison of Clauss fibrinogen and fibrinogen measurement derived from aPTT and PT in diabetes mellitus and correlations with markers of glycemic equilibration
Ripoll L. - Differential geographic distribution of Factor V Leiden and Factor II Leiden in a French native population (the Fitenat study)
  - There is no north/south gradient distribution of the plasma fibrinogen level and of the C-148T Fg genotype in a French native population (The Fitenat Study)
Risato R. - Contemporary total hip and knee replacement in A patients with haemophilia and high titre of inhibitors to FVIII by using recombinant FVIIa (novoseven) continuous infusion
  - Intron 1 factor VIII gene inversion in patients with severe hemophilia A
Rischewski J. - Use of recombinant factor VIIa in severe acquired coagulopathies in childhood
Rison C. - The sensitivity and specificity of ADAMTS13 activity for primary thrombotic thrombocytopenic purpura
Rivard R. - Patterns of factor prophylaxis in the Canadian hemophilia A population
Rivard G. E. - Clear familial co-segregation of the type 1 von Willebrand disease phenotype and VWF haplotypes in the Canadian type 1 VWD study
  - Platelet-dependent alterations in fibrinolysis in the Quebec platelet disorder
  - An ancient von Willebrand Disease (VWD) mutation that associates with a common haplotype in ~14% of type 1 VWD patients
Rivard G. - Final results from the Canadian hemophilia dose escalation prophylaxis trial
Rivera J. - Pharmacogenetics in the thrombolytic treatment of myocardial infarction: role of the FXIII V34L polymorphism
  - Detection of conformational transformation of antithrombin in blood by crossed immunoelectrophoresis: new application for a classical method. Effect of temperature in plasmatic antithrombin; role in senescence of antithrombin and thrombosis
  - Analysis of the HPS-1 gene in patients with single platelet dense-granule deficiency and mild bleeding diathesis
Rivera S. - Changes at thromboprophylaxis in a Peruvian hospital from 1996 to 2000
Rivera J. - Genetic variations of the extra-large stimulatory G protein a-subunit and risk of thrombotic and hemorrhagic disorders
Rizzatti E. G. - Psychologic impact of thrombophilia screening in asymptomatic relatives of carriers of prothrombotic mutations
  - Thrombotic risk in first-degree relatives of factor V Leiden (FVL) and factor II G20210A carriers
Rizzo D. - Increased procoagulant activity and impaired fibrinolytic potential in blood mononuclear cells after coronary angioplasty for stable or unstable angina
Rizzon P. - Increased procoagulant activity and impaired fibrinolytic potential in blood mononuclear cells after coronary angioplasty for stable or unstable angina
Roa D. C. - CD39 ecto-nucleotidase activity (metabolizing ATP to ADP to AMP) constitutes a homeostatic mechanism for control of platelet reactivity, depending on the ratio of ADPase to ATPase activity. Results from patients with coronary artery disease
Roach D. M. - Protein C levels in critically ill ICU patients: differences seen between patients with and without sepsis
Roahrig J. - Examining the role of coagulation Factor VII using FVII-insufficient mice
Robb D. - Combined carrier status of prothrombin 20210 A and factor XIII-A L34 alleles as a strong risk factor for myocardial infarction: evidence of a gene–gene interaction
Robben W. - The development and evaluation of a quality of life questionnaire for children with hemophilia
Robert A. - Importance of beta-2 glycoprotein I in the lupus anticoagulant cofactor effect: a case report
Robert K. - Effect of hyperhomocysteinemia on paraoxonase activity
Robert A. - Increased factor V level and preanalytical coagulation
Robert A. - Variations of INR and Factor VII Level are linked to Cytochrome P450 2C9 genotype
Robert A. - Multicenter evaluation of a new polymer tube (Vacuette Sandwich) for coagulation testing. Effect on routine coagulation tests and on plasma levels of markers of coagulation activation
Roberts P. L. - Inactivation of non-enveloped viruses by non-ionic detergent and solvent/detergent in the fibrinogen component of fibrin sealant
Roberts H. R. - Platelet P2Y12 inhibition decreases GPVI stimulated increases in thrombin generation on activated platelets
  - Calcium ionophore A23187 and convulxin increase Xa generation in a cell-based model of hemostasis
Roberts J. C. - Recombinant FVIIa promotes adhesion and aggregation of platelets in normal subjects and von Willebrand disease patients as measured in the PFA100™
Roberts J. R. - Crystal structure of the amino terminal domain of glycoprotein Iba in complex with a-thrombin
Roberts M. - Health care costs and clinical outcomes in patients on chronic oral anti-coagulation undergoing perioperative bridging with low-molecular-weight heparin vs. unfractionated heparin
Roberts H.R. - Impact of procoagulant concentration on rate, peak and total thrombin generation in a model system
Roberts H. - Pharmacokinetics, pharmacodynamics and tolerability of single injections of activated recombinant FVII (rFVIIa, NovoSeven®) in healthy Caucasian and Japanese subjects
Roberts G. - Single center review of clinicopathological characterization in 77 patients with positive lupus anticoagulant antibodies
Roberts H. - Development of economic and outcomes model of hemophilia treatment in Latin America and South-east Asia
Robertson L. - Screening for thrombophilia: an economic assessment
Robertson T. L. - Effect of the direct factor Xa inhibitor, DX-9065a, on thrombin generation in patients with stable coronary artery disease
Robertson L. - Thrombophilia in pregnancy, combined oral contraceptives and hormone replacement therapy users: a systematic review
Robertson L. - The risk of thromboembolism and the effectiveness of prophylactic treatment in thrombophilia patients undergoing major orthopaedic surgery: a systematic review
Robinson S. - Patterns of factor prophylaxis in the Canadian hemophilia A population
Robinson G. V. - Increased circulating cardiovascular risk factors in obstructive sleep apnoea and the effect of CPAP therapy
Robinson A. - A role for the thiol isomerase activity of a IIbb 3 in receptor clustering
Robinson S. - Final results from the Canadian hemophilia dose escalation prophylaxis trial
Robison L. M. - Economic evaluation of anti-D immunoglobulin in the treatment of immune thrombocytopenic purpura in adults in the United Kingdom
  - Economic modeling of full-length anti-hemophilic factor (recombinant), plasma/albumin-free method (rAHF-PFM), vs. B-domain deleted rFVIII (BDDrFVIII) in previously treated patients (PTPs) with hemophilia A
Rocco M. - aIIbb3 integrin activation mechanisms – switchblade or scissors?
  - Integrin clustering mechanisms explored with a soluble aIIbb3 ectodomain construct
Rocha T. R. F. - Factor VII deficiency and stroke: case report
  - Successful use of Arixtra® in a patient with PNH, Budd–Chiari syndrome and HIT
Rocha L. - Prothrombin mutation G20210A, and not factor V Leiden, is a significant risk factor for cerebral venous thrombosis in 27 Brazilian patients
Rochefort F. - Anti-thrombotic treatment after coronary artery bypass graft surgery (CABGS):economic consequence of a change in regimen
Rocino A. - Impact of prenatal/perinatal events and early FVIII replacement on inhibitor risk in children with severe hemophilia
Martinez-Marchan E. - Genetic coregulation of C4b-binding protein (C4BP) and free Protein S plasma levels: a link between complement and hemostasis
Rock G. - Functional protein S testing does not exclude protein S deficiency
Rodeghiero F. - An improved multimeric analysis identifies a subgroup of patients with Type 1 von Willebrand disease characterized by reduced VWF:RCo/Ag ratio
  - Comparison of hemorrhagic symptoms in obligatory carriers of type 1 and type 3 von willebrand disease (VWD): results from a collaborative, international, multicenter study
  - Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
  - Clinical presentation of type 1 von Willebrand disease (VWD) in obligatory carriers: final results from a collaborative, international, multicenter study
  - Contribution of factor V deficiency to the thrombotic risk associated with factor V HR2
  - Sensitivity and specificity of PFA-100® vs. bleeding time in the diagnosis of type 1 von Willebrand disease (VWD)
  - Association between fibrinogen levels and fibrinogen G-455 A polymorphism and preclinical atherosclerosis in the general population
  - Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
Rodeghiero F. - The genetics of type 1 vWD
Rodeghiero F. - Plasma-derived FXIII concentrate is as safe and effective as placenta-derived FXIII concentrate for the treatment of inherited FXIII deficiency
  - Evaluation of a new quantitative, rapid test (VWF-LIA) for the diagnosis of type 1 VWD
Rodger M. A. - The bedside investigation of pulmonary embolism diagnosis (BIOPED) study- a triple blind randomized control trial comparing initial bedside diagnostic tests to standard care (initial V/Q scan) in the investigation of patients with suspected PE
Rodger M. - Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
Esparza-Gordillo J. - Genetic coregulation of C4b-binding protein (C4BP) and free Protein S plasma levels: a link between complement and hemostasis
Rodger M. A. - Functional protein S testing does not exclude protein S deficiency
Rodgers S. E. - Analysis of adult patients with von Willebrand disorder in South Australia
Rodgers G. M. - Polymorphisms in the 5'UTR of the tissue factor (TF) gene are associated with differences in total and surface clotting activity and TF mRNA of endothelial cells
Rodgers S. E. - Low detection rate of antibodies to nonfunctional epitopes on factor VIII in patients with hemophilia A and negative for inhibitors by Bethesda assay
Rodrigues I. - Evaluating the interaction of allopurinol with the oral anticoagulants
Rodrigues C. A. - Prothrombin mutation G20210A, and not factor V Leiden, is a significant risk factor for cerebral venous thrombosis in 27 Brazilian patients
Rodríguez S. - Comparison of template bleeding time and PFA-100 as screening tests in 175 consecutive patients with hereditary mucocutaneous hemorrhages (MCH)
Rodriguez M. H. - Human factor IX expression in megakaryocytes derived from electrophorated human hematopoietic cells
Rodriguez L. - Acquired platelet dysfunction with eosinophilia in children: A tropical disease present in Venezuela
Rodríguez I. - Retrospective study of acquired factor VIII inhibitor
Rodríguez S. - Patients with mild hereditary bleeding disorders have normal thrombin generation (TGPPP) in platelet poor plasma
Rodriguez J. A. - Proteolytic pattern in advanced atherosclerotic human lesions: relation to vascular bed, plaque features, and cardiovascular risk factors
Rodriguez De Codoba S. - Genetic coregulation of C4b-binding protein (C4BP) and free Protein S plasma levels: a link between complement and hemostasis
Roemisch J. - Factor VII activating protease is an inhibitor of platelet derived growth factor-BB-mediated migratory and mitogenic activities on vascular cells
Roes E. - Preconceptional, gestational and puerperal low anti-annexin A5 antibody levels in women who develop pre-eclampsia
Roest M. - Elevated levels of d-dimer and fragment 1 + 2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis
  - Coronary risk prediction and the role of C-reactive protein
Roettgen P. - Human, conformation-specific, anti-GPIIb/IIIa (aIIbb3) single-chain antibodies generated by differential phage-display: a new generation of platelet inhibitors specific for the activated GPIIb/IIIa receptor?
Rogge M. - Pharmacokinetics of recombinant human FXIII in cynomolgus monkeys
Rogolino A. - Rate of adverse events during OAT in patients with mechanical prosthetic heart valves replacement
  - Increased lipoprotein(a) levels as an independent risk factor for idiopathic and recurrent venous thrombosis
Rogolino A. - Hemostatic changes in laparoscopic and laparotomic gynecological surgery
Rogova E. M. - Platelet activity and circulating leukocyte-platelet aggregates can be markers of thrombotic and inflammatory processes in patients with coronary atherosclerosis
Rogy S. - Clinical evaluation of an advanced category recombinant FVIII, anti-hemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in pediatric previously treated patients (PTPs)
Rohde S. - Increased thrombophilic abnormalities in patients with cranial dural arteriovenous fistulae
Rohlena J. - Role of factor IX surface loop 342–347 in factor VIII-mediated enhancement of catalytic activity
Rohner M. - Nonmechanical intraoperative bleeding diathesis shows properties of a consumptive disorder allowing preoperative risk stratification
Rohoza A. - Anti-fibrinogen IgG from a thrombophilic A alpha R16C (Fibrinogen Northspring) proband accelerates release of clot bound thrombin by enhancing fibrinolysis: a novel thrombogenic mechanism
Rojer R. - Levels of endothelial activation markers, D-dimer fragments and pro-inflammatory cytokines and sickle cell disease severity
  - Reduced protein C and S activity and sickle cell disease severity
  - Elevated steady state serum sVCAM-1 levels occur from an early age in sickle cell patients, but are not related to vasoocclusive crises and acute chest syndrome frequency
Rojkjaer R. - Colocalization of recombinant human factor VIIa with its substrates on highly procoagulant COAT-platelets
Rojkjaer L. P. - Hemostatic effect of rFVIIa (NovoSeven®) in a mouse model of type 1 von Willebrand disease (VWD)
Rojkjaer R. - Hemostatic effect of rFVIIa (NovoSeven®) in a mouse model of type 1 von Willebrand disease (VWD)
  - Enhanced procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in plasma from patients with severe haemophilia A
  - Hemostatic effect of three factor VIIa analogs in antibody-induced hemophilia A in mice
Roldán V. - Pharmacogenetics in the thrombolytic treatment of myocardial infarction: role of the FXIII V34L polymorphism
Roldan V. - Myocardial infarction in young patients: risk factors and thrombophilia study
  - Hemostatic markers in nonrheumatic atrial fibrillation patients without anticoagulant therapy
Rolfe-Vyson V. - The rate of thrombus resolution following treatment of DVT is related to the site and the precipitating cause of thrombosis
Rolfsen S. - Elevated concentrations of nitrate in plasma from smokers
  - Prevalence of hyperhomocysteinemia among aluminum industry workers
Rollin J. - Transcriptional silencing of TFPI-2 gene by hypermethylation of the promoter in choriocarcinoma cells
Rollin J. - Quantitative evaluation of TFPI-2 and MMP-9 expression in nonsmall cell lung cancer
Rollo H. A. - Prophylaxis of deep vein thrombosis after lower extremity amputation: comparison of low molecular weight heparin with unfractionated heparin
Román A. - Hypercoagulability in cerebrovascular disease (CD): factor V Leiden, prothrombin G20210A and MTHFR C677T mutations and polymorphism in the annexin V kozac sequence
Romani De Wit T. - Real-time imaging of the dynamics and secretary behavior of Weibel–Palade bodies
Romano P. S. - The epidemiology of venous thromboembolism in California
Rombout E. - Storage of apheresis platelets leads to reduced adhesiveness and thrombogenic activity in flowing whole blood ex vivo
Romeu J. - Quantitative real-time reverse transcription-PCR (RT-PCR) assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1 and tissue metalloproteinase inhibitor type 1 gene expression and protein levels in endometriosis
Romijin R. - The sensitivity and specificity of ADAMTS13 activity for primary thrombotic thrombocytopenic purpura
Romijn F. P. H. - Antigenic characterization of endothelial cell-derived microparticles and their detection ex vivo
Romijn R. A. P. - Identification of the bitiscetin-binding site on the von Willebrand factor A3-domain. Comparison to the collagen-binding site
Romijn F. P. H. TH. M. - Soluble tissue factor released by cultured human umbilical vein endothelial cells is microparticle-associated and triggers thrombus formation in vivo
Romisch J. - The modulation of lipopolysaccharide induced gene expression and protein production by anti-thrombin
Roncal C. - The endothelial expression of pai-1 by Angiotensin II is dependent on the 4 g/5 g polymorphism: clinical and therapeutic implications
  - Pravastatin modulates the cytokine-induced endothelial expression of PGE2: A novel anti-inflammatory mechanism of cholesterol-lowering drugs
Rondaij M. G. - Real-time imaging of the dynamics and secretary behavior of Weibel–Palade bodies
Rondaij M. - The small GTP-binding protein Ral is involved in cAMP-mediated release of VWF from endothelial cells
Roosendaal G. - Effects of bleeds on health-related quality of life in patients with hemophilia
Rosafalco M. - Oral anti-coagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS)
Roschitz B. - Increased von-Willebrand-facor-binding to platelets in neonatal plasma
Rose P. - Evaluation of a clinical algorithm in nurse led DVT management to identify underlying malignancy
  - Baseline characteristics, risk factor profile and outcomes of patients treated for venous thromboembolic disease with low molecular weight heparin (enoxaparin) – the Venous Thromboembolism Registry (VERITY)
  - The effects of thalidomide analogues on VEGF and IL-6 production in myeloma and endothelial cell cocultures
Roselli M. - Soluble CD40 ligand (sCD40L) plasma levels in nonsmall cell lung cancer
Rosen E. D. - In vivo activated protein C (APC) neuroprotective activity involves endothelial protein C receptor (EPCR) and protease activated receptor 1 (PAR-1)
Rosen E. - Examining the role of coagulation Factor VII using FVII-insufficient mice
Rosenberg N. - Aging of ancestral mutations causing factor VII deficiency and Dubin–Johnson syndrome in Iranian and Moroccan Jews reflects ancient Jewish migrations
Rosenberg R. D. - Persistent biochemical hypercoagulability and risk of death from cancer in middle-aged men
Rosenberg N. - The molecular basis of Glanzmann thrombasthenia in Arabs
Rosenberg N. - Substitutions of conserved Gly193 (numbering according to chymotrypsin) located near the catalytic triad of factors VII, IX and XI yield dysfunctional proteins probably due to interference with accessibility of the respective substrates
  - Thrombophilia does not increase the risk for neonatal complications in preterm infants
Rosenberg R. - Thrombin generation after ischemic stroke: the hemostatic system activation study (HAS)
Rosencher N. - Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis
  - Efficacy and safety of the treatment regimen of melagatran and ximelagatran for prevention of thromboembolic events after total hip or knee replacement: a meta-analysis of 3 randomized, double-blind studies, to evaluate the influence of time and dose
Rosendaal F. R. - Homocysteine lowering by B vitamins and the prevention of secondary deep-vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial
Rosendaal F. - Lower degree of protein C activation in protein C deficient individuals of a large kindred with type I PC deficiency, as measured by the level of APC-PCI complex
Rosendaal F. R. - Risk of venous thrombosis for patients with various malignancies and with factor V Leiden or the prothrombin 20210 A mutation: the MEGA case–control study
  - Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci
  - Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
Rosendaal F. - Asymptomatic venous thrombosis is a frequent event in protein C deficiency: a systematic ultrasound assessment of 208 family members with the 3363-C insertion mutation (IPCI: International Protein C Investigation)
Rosendaal F. R. - The development and evaluation of a quality of life questionnaire for children with hemophilia
  - Questioning the questionnaire: a sensitivity analysis for data collection on venous thrombosis
  - Post-thrombotic complaints are not related to factor V Leiden mutation or elastic compression stockings: results of the MEGA Study
  - Elevated plasma cysteine concentration as a risk factor for venous thrombosis
  - Prescribing anticoagulant prophylaxis in patients with hematological or solid tumor malignancies and central vein catheters: a nationwide survey
Rosendaal F. R. - Estrogens, progestogens and thrombosis
Rosendaal F. R. - Plasma levels of the pro-inflammatory mediators TNF-alpha, IL-6 and IL-8 are risk factors for venous thrombotic disease
  - An evaluation of 30 years of hemophilia treatment in the Netherlands
  - Heritability of clotting factors and the prothrombotic state: results from a large thrombophilic pedigree of French Canadian descent with Type I protein C deficiency
  - Procoagulant factors and the risk of myocardial infraction in young women
  - The thrombotic risk of different types of oral contraceptives and interaction with factor V Leiden and the prothrombin 20210 A mutation: results of the MEGA study
  - Quality of life and risk perception in a large family with heritable protein C deficiency (IPCI: International Protein C Investigation)
  - Is isolated postmethionine-load hyperhomocysteinemia a separate risk factor for venous thrombosis?
  - Common genetic abnormalities in blood coagulation (Factor V Leiden, prothrombin G20210A) increase the incidence of central vein catheter related thrombosis
  - A new computer algorithm for better dosage of oral anti-coagulants
  - Mortality of Dutch hemophilia patients, a prospective follow-up of 973 patients, 1992–2002
  - Risk factors for recurrent venous thrombosis: a prospective follow-up of the Leiden thrombophilia study (LETS)
  - Screening for annexin A5 gene mutations and the risk of the C-1T mutation in venous thrombosis and myocardial infarction
  - Incidence of thrombosis in gastro-esophageal cancer: a cohort study of 649 patients
Rosey G. - Effect of in vivo thrombin inhibition on bFGF-induced angiogenesis in a murine angiogenic model
Rosing J. - Impaired anticoagulant activity of factor V accounts for a large fraction of the APC resistance associated with the FV Leiden (R506Q) and R2 (H1299R) mutations
Rosing J. - APC resistance, new perspectives
Rosing J. - Functional properties of recombinant factor Va mutated in a potential calcium-binding site
  - Changed inactivation pathway of factor Va by activated protein C in the presence of heparin
  - The regulation of thrombin formation by protein S in plasma in the absence of APC
  - Venous thrombosis and APC resistance during hormone treatment in male-to-female transsexuals
  - Activated factor V is inactivated by activated protein C in the absence of APC cleavage sites at Arg306, Arg506 and Arg679
  - IgG antiprothrombin antibodies from patients with antiphospholipid syndrome inhibit the inactivation of Factor Va by activated protein C
  - Functional characterization of recombinant factor V molecules mimicking the R2-haplotype
van Oerle R. - Functional impairment of protein S in carriers of the prothrombin G20210A mutation
Rosing J. - Enhanced thrombin generation and mild bleeding tendency in a severely FVII-deficient patient carrying FV Leiden
  - Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool
Rosner B. - Thrombin generation after ischemic stroke: the hemostatic system activation study (HAS)
Ross B. L. - Fibrinolysis within the procoagulant VX-2 tumor of rabbit lungs in vivo: Anti-angiogenic behavior of fibrin(ogen) degradation products
Ross C. - The three I hemophilic study: a comparative study of the morbidity pattern between Asian Indian, Iranian and Italian PWH
Rosser J. - Agreement between FXIII activity assays and calibrator plasma pools: the need for a FXIII reference standard with regulatory recognition
Rossetti G. - Efficacy of Haemate P in the management of patients with von Willebrand disease undergoing surgery
Rossi F. - Platelet-associated Tissue Factor: modulation of cell surface expression by platelet agonists
  - Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study
Rossi M. - Management of oral anticoagulant therapy in the perioperative period: preliminary results of the application of an operative protocol
Rossi L. - Optimization of human 14 000 oligonucleotide-microarrays and study design for the evaluation of gene expression profiling in cardiovascular diseases
Rossi E. - A case of multiorgan atherosclerotic disease in patient affected by hyperhomocystinemia with multiple heterozygous mutations
  - Risk for recurrent venous thromboembolism among patients with severe inherited thrombophilia
Rossi R. - Lysosomal beta-N-acetylhexosaminidase is a primer of platelet activation
Rossi R. - A clinical outcome-based prospective study on venous thromboembolism in cancer surgery: the @RISTOS project
Rossi E. - Risk for recurrent venous thromboembolism after a first superficial vein thrombosis among carriers of inherited thrombophilia
Rossi M. - Risk factors for venous thromboembolism in chronically bedridden patients admitted to the Hospice Unit
Rossi E. - Risk for venous thromboembolism among younger or older carriers of inherited thrombophilia
Rossi L. - Evaluation of the fibrinolytic capacity before and after venous occlusion performed by serum d-dimer test after standardized coagulation
Rossi E. - Inherited thrombophilia and associated risk for unexplained fetal loss
  - Risk for venous thrombosis in unusual sites associated with inherited thrombophilia: analysis of 133 patients
Rossiello M. R. - Increased procoagulant activity and impaired fibrinolytic potential in blood mononuclear cells after coronary angioplasty for stable or unstable angina
Rossignol P. - Protease-nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells
Rost S. - Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
Rostworowski W. - Sialic acid and lipid contents of low density lipoprotein in relation to platelet receptor activity
Roszak K. - Changes in von Willebrand factor concentration and blood loss during cardiac surgery
Roszkowski K. - Compression ultrasound in diagnosis of asymptomatic deep venous thrombosis
Roth A. W. - Randomized, double-blind comparison of ximelagatran, an oral direct thrombin inhibitor, and warfarin to prevent venous thromboembolism (VTE) after total knee replacement (TKR)
Rothschild C. - Extracorporeal adsorption of Factor VIII antibodies on randomly functionalized polystyrene resins
Rothschild C. - Efficacy and safety of the first nanofiltered plasma-derived FVIII (FACTANE®) in previously treated haemophilia A patients
  - Effect of type of treatment (recombinant vs. plasmatic) on FVIII inhibitor incidence according to known risk cofactors in previously untreated severe hemophilia A patients (Pups)
Rothwell P. - ‘Aspirin resistance’ detected by high shear platelet function testing within the pilot phase of the Oxford Vascular Study (OXVASC)
  - Markers of hemostatic activation and protein Z in acute stroke and myocardial infarction: a community based pilot study
Rotilio D. - Pharmacological and cellular bases of some anti-thrombotic properties of extravirgin olive oil: studies on oleuropein and hydroxytyrosol
Rotondo S. - Pharmacological and cellular bases of some anti-thrombotic properties of extravirgin olive oil: studies on oleuropein and hydroxytyrosol
Roubey R. A. S. - Cell surface annexin A2 (ANX2) mediates the up-regulation of monocyte tissue factor activity by b2-glycoprotein I (b2GPI) and anti-b2GPI autoantibodies
Roubey R. A. S. - Inhibition of anti-phospholipid antibody-induced monocyte tissue factor activity by dipyridamole and dilazep: role of adenosine
Rouillon A. - Does DVT exist in Asia? – The AIDA study (assessment of the incidence of Deep Vein Thrombosis in Asia following major orthopedic surgery): study rationale and interim results
Roumen-Klappe E. - IL-6 concentration in the acute phase of deep-vein thrombosis is a strong predictor of elevated venous outflow resistance as a proxy of post-trombotic syndrome
  - Venous outflow resistance can be used after acute deep-vein thrombosis as a screening test to identify patients at risk of the post-trombotic syndrome
  - Compression bandaging in the acute phase of deep-vein thrombosis reduces symptoms but does not decrease venous outflow resistance and thrombosisscore as a proxy of the post-trombotic syndrome
Roussanne M. C. - Evidence for extracellular signal-regulated kinase 1/2 activation by thrombin that is independent on epidermal growth factor receptor transactivation in vascular smooth muscle cells
Roussel-Robert V. - A retrospective evaluation of the use of B-domain deleted recombinant Factor VIII (ReFacto®) administered by continuous infusion during surgical procedures
Roussi J. - Age influence on D-Dimer in a large normal French population: the FITENAT study
Roussin A. - Resource utilization and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis
Roussoulieres A. L. S. - Identification and characterisation of MIP-1b and VE-Cadherin as important markers of acute rejection after human heart transplantation
Rowlings P. - Using ETP to predict which factor V Leiden heterozygotes will suffer from venous thrombo-embolism
Rox J. - Induction of monocytic tissue factor (TF) expression: an additional mechanism of action of desmopressine acetate (DDAVP)
Rox J. - Gene expression analysis in platelets: use of a PCR-based RNA amplification technique for generating suitable amounts of cDNA
Rox J. - Tissue factor (TF) gene expression analysis in blood monocytes
Roy P. M. - Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism
Roy P. - Abciximab therapy post elective coronary artery stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin and platelet-monocyte aggregates
Roy P. M. - Diagnosing pulmonary embolism with clinical assessment, d-dimer, venous ultrasound and helical computed tomography: a multicenter management study
Roy A. - Bleeding in patients with factor XII deficiency may relate to concomitant platelet function disorders if von Willebrand's disease is excluded
  - Peri-operative bleeding in patients with Pseudomyxoma peritonei appears to relate to trauma induced hypofibrinogenemia
Roy P. M. - Clinical usefulness of D-dimer according to clinical probability in patients with suspected pulmonary embolism
Royds R. - A dose–response study of a recombinant human soluble thrombomodulin (ART-123) for prevention of venous thromboembolism after unilateral total hip replacement
Royle D. E. - Does thromboelastography demonstrate hypercoagulability in patients with both a clinical history of thrombosis and the lupus anti-coagulant antibody?
Royle E. - Residual platelet function can be detected in patients on antiplatelet therapy using novel Hemoscope reagents and standard Thrombelastograph® (TEG®)
Royle D. E. - Factor VII Padua: diagnosis based on differential laboratory tests
Rozenshteyn D. - Repression of integrin a1 gene (ITGA1) expression in human megakaryocytes coincides with DNA methylation of the core promoter
Rozmyslowicz W. - Thrombolytic effect of AT1 receptor antagonists – losartan and its metabolite EXP 3174 in rat
Rozponczyk E. - Biological and pharmacokinetic activity of the new recombinant thrombolytic and anthithrombotic agent RGD SAK-K2-HIR
Ruan C. - A novel point mutation in the transmembrane domain of the platelet glycoprotein IX associated with bernard–soulier syndrome
  - Quantitative analysis of gene expression for vascular endothelial growth factor and its application
  - The frequency of P475S polymorphism in von Willebrand factor-cleaving protease among Chinese population and its relevance to arterial thrombotic disorders
Ruan C. - Soluble platelet GPV: a new marker of thrombosis status
Ruan C. - Establishment of urokinase receptor gene antisense RNA transfer system and its influence on uPAR expression in leukemia cells
Ruan J. - Biochemical, immunologic and computer-modeling evidence localizing the mAb 7E3 Epitope on aIIbb3
Ruan L. - Downregulation of Factor IXa in the Factor Xase complex by protein Z-dependent protease inhibitor (ZPI)
Ruan C. - A recombinant von Willebrand factor fragment inhibits binding of von Willebrand factor to glycoprotein Ib-IX
Rubattu S. - Enhanced TNF-a and oxidative stress in patients with heart failure: effect of TNF-a on platelet O2 production
Rubis P. - Anti-phospholipid antibodies and carotid-artery intima-media thickness in young survivors of myocardial infarction
Rudakov V. E. - Dynamics of changes of parameters of a hemostasis in patients with sepsis
  - Laboratory (on base coagulological tests) it is latent proceeding hematogenous thrombophilias
Rudakova V. E. - Dynamics of changes of parameters of a hemostasis in patients with sepsis
Rudd A. - Performance characteristics of the VIDAS and IL test d-dimer (d-d) assays as exclusionary tests for venous thromboembolism (VTE) after acute ischemic stroke (AIS)
  - The relationship between acute ischemic stroke (AIS) per se and plasma D-D (D-D) levels
  - Recognized and unrecognized clinical venous thromboembolism (VTE) after acute ischemic stroke (AIS): a prospective study using magnetic resonance direct thrombus imaging (MRDTI)
  - The relationship between plasma D-dimers (D-d) and thrombus load in patients with deep vein thrombosis (DVT) after acute ischaemic stroke (AIS): a prospective study using magnetic resonance direct thrombus imaging (MRDTI)
Rudko I. - Platelet–neutrophil interaction in Chernobyl wreckers accident liquidators
Ruf A. - Human antibody against CD11b inhibits platelet–leukocyte interaction under high shear
  - Comparison of two methods to assess platelet activation during and after CABG
Ruf A. - Platelet function under aspirin, clopidogrel and both after ischemic stroke. A case-crossover study
Ruf W. - Specificity of coagulation factor signaling
Ruf W. - Tissue factor pathway inhibitor-2 (TFPI-2) binds the complement and kinin binding protein gC1qR/p33 (gC1qR)
Rüfer A. - Routine homocysteine monitoring: stabilization of blood samples with fluoride
Rugal V. - Xenogenic immunoglobulins can be used in treatment coagulation disorders
Rugeri L. - Thrombin generation in von Willebrand diseases
Ruggeri Z. M. - Modulation of von Willebrand factor A1 domain binding to glycoprotein Iba by a-thrombin
Ruggeri Z. M. - Von Willebrand factor, platelets and endothelial cell interactions
Ruggeri Z. M. - Crucial role of the ADP receptor P2Y1 in platelet adhesion and signaling under high flow
Ruggeri Z. - A key role of the fast ATP-gated P2 X 1 cation channel in the thrombosis of small arteries in vivo
Ruggeri Z. M. - Identification of a quantal unit mediating platelet tethering and microparticle formation through glycoprotein Ibalpha–VWF interaction
Ruggeri A. M. - Crystal structure of the amino terminal domain of glycoprotein Iba in complex with a-thrombin
Ruggeri Z. M. - Increased shear rate threshold in mouse blood for the dependence of platelet thrombus formation on glycoprotein Iba
Ruggeri Z. - Impaired thrombus formation in a murine model of glycoprotein VI deficiency
  - A key role of the fast ATP-gated P2X1 cation channel in the thrombosis of small arteries in vivo
Ruggeri Z. M. - The P2X1 receptor for ATP plays an essential role in platelet aggregation at high shear
Ruiz M. L. - Deep venous thrombosis of the arm: comparison of sulodexide and acenocoumarol for the secondary prevention of venous thromboembolism
Ruiz-Sáez A. - Acquired platelet dysfunction with eosinophilia in children: A tropical disease present in Venezuela
  - Factor XI deficiency in Mestizo Venezuelan population
Rumley A. - Population prevalence of atrial fibrillation and factors associated with use of warfarin
Rumley A. - Associations of hemostatic and inflammatory variables with obesity and blood pressure in men and women aged 30–59 years: cross-sectional population survey
Rumley A. - Associations of hemostatic and inflammatory variables with prevalent myocardial infarction, angina and stroke in British men: British Regional Heart Study
Rumley A. - Effects of age, sex, and oral contraceptive use on hemostatic, fibrinolytic and inflammatory variables: cross-sectional population survey
Rumley A. - Effect of bezafibrate on plasma homocysteine in men with lower extremity arterial disease
  - Coagulation activation markers in atrial fibrillation: dose-dependent correlation with warfarin therapy
Rumley A. G. - Is homocysteine an independent risk factor for myocardial infarction? Results from the Glasgow myocardial infarction study
Rumley A. - Is homocysteine an independent risk factor for myocardial infarction? Results from the Glasgow myocardial infarction study
Rupin A. - Influence of selective nonpeptide PAR-1 and PAR-4 antagonists on thrombin-induced aggregation of human platelets
Rupin A. - Anti-thrombotic and anticoagulant effects of S35898 an orally active thrombin inhibitor
Rupin A. - Evolution of a nonocclusive deep vein thrombosis in the rabbit vena cava
  - Role of NADPH oxidase on mechanisms implicated in anoxia/reoxygenation-induced leukocyte adhesion to HUVECs
Rurgkhum S. - Cost-effectiveness in establishing carrier detection and prenatal diagnosis services in a developing country with limited health resources
  - Prevalence of Arg 506 and Arg 306 mutations of the factor V gene in Thai blood donors
Rus C. - Anti-protein S antibodies in patients with venous and/or arterial thrombosis
  - Prolonged APTT children undergoing elective tonsillectomy
Rusconi C. P. - Effect of a RNA-thrombin aptamer on thrombin inhibition by antithrombin, heparin cofactor II and protein C inhibitor
Rushbrook J. I. - Genomic structure, organization and promoter analysis of the human F11 receptor (F11R) (junctional adhesion molecule-1, JAM-1)
Rusicke E. - Clinical manifestation and therapy in children with hereditary angioedema (HAE) – a prospective follow up
Rusicke E. - Favourable course of hemorrhagic complication in early pregnancy of a patient with congenital afibrinogenemia under replacemant therapy
  - F VIII:C, Ristocetin-cofactor and von Willebrand factor in children with venous thrombosis or cerebral infarction
Russell K. E. - The development of pro-hemostatic lyophilized platelets with minimized risk for intravascular coagulation
Russell S. - Impaired thrombus formation in a murine model of glycoprotein VI deficiency
  - Regulation of megakaryocyte polyploidization and platelet release by the cytoplasmic tail of glycoprotein Iba
Russo V. - Transdermal hormone replacement therapy does not affect hemostasis and inflammation
Rustagi P. - A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Rutengwe R. M. - The effect of refined and red palm olein compared to sunflower oil on lipids and homeostatic factors in hyperfibrinogenemic patients
Rutz T. - Proteolysis of tissue factor pathway inhibitor-1 on circulating microparticles after thrombolysis in acute myocardial infarction contributes to thrombin formation
Ruud E. - Family history of thromboembolism does not identify children with thrombophilia – A cross-sectional study
Ruybalid L. - Reliability of patient self-testing and point-of-care testing with the Harmony (TM) INR monitoring system: a 3-year study
Ruybalid L. R. - Maintenance of patient vs. professional competence with patient self testing of the INR – a 6-year experience
Ruybalid R. L. - Precision of INR (International Normalized Ratio) measurement using laboratory and point-of-care assays: Understanding the impact of system influence on patient management
Ryabysh E. - The influence of treatment with low molecular weight heparins (dalteparin, nadroparin) on the clinical course and hemostasis activation markers in patients with unstable angina
Ryota O. - Hypercoagulation and elevated blood pressure induced by phosphatidylserine/phosphatidylcholine microvesicles in pregnant mice can be suppressed by heparin and annexin V
Rys A. - Cerivastatin neither inhibits thrombin generation nor decreases markers of inflamation in patients with APS
Ryu C. - Inhibitory mechanism of rat aortic vascular smooth muscle cell proliferation by NQ12, a novel antithrombotic agent
  - The anti-platelet activity of J78 is mediated mainly by inhibition of arachidonic acid metabolism